IMG - phellinus linteus mycelium tablet 
Yein Trading & Global Co., Ltd

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Drug Facts

phellinus linteus mycelium

Zinc gluconate 3% (14.34% as Zinc), Vitamin C 10% (100% as vitamin C), Lactose 41%, Cordyceps militaris extract powder (mycelium culture) 6%, Chaga mushroom extract powder (mycelium culture) 6%, Ganoderma lucidum extract powder (mycelium culture) 6%, Trametes versicolor extract powder (mycelium culture) 6%, Grifola frondosa (mycelium culture) 6%, Hydroxypropylmethyl-cellulose 4%, Cultured Wild ginseng root powder 3%, Carboxymethylcellulose calcium 2%, Magnesium stearate 1%

antitumor effect
prophylactic effect
immunostimulating effect
synergistic effect

keep out of reach of the children

1. ulterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication
2. reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation form the patient with cancer in digestive system or liver

- digestive system:  occasionally, vomiturition, vomiting, loss of appetite and diarrhea might occur, and infrequently malaise in stomach might take place
- the others:  dizziness (1 case), headache (1 case), constipation (3 cases) were reported in clinical test of this medicine

- uterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication : as a phellinus linteus mycelia extracts, administer 550~1100mg 2 times per a day before having a meal by mouth
- reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation for the patient with cancer in digestive system or liver :  as a phellinus linteus mycelia extracts, administer 1100mg 3 times per a day after having a meal by mouth

package insert
IMG 
phellinus linteus mycelium tablet
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:53144-3001
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PHELLINUS LINTEUS MYCELIUM (UNII: 40K19XJV3C) (PHELLINUS LINTEUS MYCELIUM - UNII:40K19XJV3C) PHELLINUS LINTEUS MYCELIUM 0.022 
Inactive Ingredients
Ingredient Name Strength
ZINC GLUCONATE (UNII: U6WSN5SQ1Z)  
ASCORBIC ACID (UNII: PQ6CK8PD0R)  
LACTOSE (UNII: J2B2A4N98G)  
REISHI (UNII: TKD8LH0X2Z)  
TRAMETES VERSICOLOR FRUITING BODY (UNII: 4C900477MT)  
GRIFOLA FRONDOSA WHOLE (UNII: O238UC53ET)  
HYPROMELLOSES (UNII: 3NXW29V3WO)  
CARBOXYMETHYLCELLULOSE CALCIUM (UNII: UTY7PDF93L)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
Product Characteristics
Color brown (light brown) Score no score
Shape OVAL (pill) Size 15mm
Flavor Imprint Code 3;hp;x
Contains     
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:53144-3001-1 60 in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 02/16/2013
Labeler - Yein Trading & Global Co., Ltd (557803795)
Registrant - Yein Trading & Global Co., Ltd (557803795)
Establishment
Name Address ID/FEI Business Operations
Han Kook Sin Yak Pharmaceutical Co., Ltd. 689277536 manufacture(53144-3001)

Revised: 2/2013
Document Id: a32e5228-31a4-4d90-aabb-40e177bf72fe
Set id: 44b31b35-8176-4f5b-bcca-3b7c17eccd98
Version: 1
Effective Time: 20130226
 
Yein Trading & Global Co., Ltd